Psychotherapy and medication management strategies for obsessive-compulsive disorder
- PMID: 21931490
- PMCID: PMC3173031
- DOI: 10.2147/NDT.S13205
Psychotherapy and medication management strategies for obsessive-compulsive disorder
Abstract
Obsessive-compulsive disorder (OCD) is a chronic anxiety disorder. While medication and psychotherapy advances have been very helpful to patients, many patients do not respond adequately to initial trials of serotonergic medication or cognitive-behavioral therapy (CBT) and require multiple treatment trials or combination therapies. Comorbidity may also influence treatment response. The role of streptococcal infections in pediatric OCD has become an area of intense scrutiny and controversy. In this article, current treatment methods for OCD will be reviewed, with special attention to strategies for treating OCD in children and in patients with comorbid tic disorders. Alternative psychotherapy strategies for patients who are highly anxious about starting CBT, such as cognitive therapy or augmentation with D-cycloserine, will be reviewed. Newer issues regarding use of antibiotics, neuroleptics, and glutamate modulators in OCD treatment will also be explored.
Keywords: OCD; PANDAS; exposure/response prevention therapy; tic disorder.
References
-
- Murray CJL, Lopez AD. Global Burden of Disease. Vol. 1. Boston, MA: World Health Organization; 1996.
-
- Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094–1099. - PubMed
-
- Castle DJ, Deale A, Marks IM. Gender differences in obsessive compulsive disorder. Aust N Z J Psychiatry. 1995;29:114–117. - PubMed
LinkOut - more resources
Full Text Sources